Form 4: Alexandria Real Estate Equities Sells Shares of Applied Therapeutics

Alexandria Real Estate Equities, a significant shareholder of Applied Therapeutics, has sold a portion of its common stock holdings through its subsidiaries.

Summary

• Alexandria Real Estate Equities, Inc., through its subsidiaries Alexandria Venture Investments, LLC and Alexandria Equities No. 7, LLC (AE7), sold shares of Applied Therapeutics, Inc. (APLT).
• On June 4, 2024, 150,000 shares were sold at a weighted average price of $4.21, with prices ranging from $4.12 to $4.32.
• On June 5, 2024, an additional 150,000 shares were sold at a weighted average price of $4.24, with prices ranging from $4.10 to $4.40.
• Following these transactions, Alexandria Venture Investments, LLC holds 5,855,077 shares, and AE7 holds 203,977 shares.
• Alexandria Real Estate Equities, Inc. remains a 10% owner of Applied Therapeutics.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative. While the filing itself is a routine disclosure, the sale of shares by a major shareholder like Alexandria Real Estate Equities could be interpreted as a lack of confidence in the company's near-term prospects, though it could also be for portfolio rebalancing.

Negatives

• Alexandria Real Estate Equities reduced its stake in Applied Therapeutics through share sales.

Risks

• Continued selling pressure from Alexandria Real Estate Equities could negatively impact APLT's stock price.
• The reason for the sale is not disclosed, which could create uncertainty among investors.

Industry Context

Form 4 filings are standard disclosures for significant shareholders and insiders, providing transparency into their trading activities. These filings are closely watched by investors to gauge sentiment and potential future actions by major stakeholders.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for insiders and large shareholders, similar to filings made by other major investors in publicly traded companies.
• The sale of shares by Alexandria Real Estate Equities is not uncommon, as investment firms regularly adjust their portfolios based on their investment strategies and market conditions.
• Comparable companies in the biotechnology sector often see similar Form 4 filings from their major shareholders.

Stakeholder Impact

• The sale of shares could create uncertainty among shareholders of Applied Therapeutics.
• The stock price of Applied Therapeutics may be negatively impacted by the sale.

Key Dates